PRESS RELEASE published on 02/26/2024 at 14:00, 2 years 7 months ago FSD Pharma Signs Agreement With Ingenu CRO to Conduct a Clinical Trial To Determine the Safety and Efficacy Effects of its Proprietary Blend Beverage unbuzzd(TM) FSD Pharma Inc. announced an agreement for a clinical trial to test unbuzzd™ effects on faster alcohol metabolism. The trial aims to confirm the supplement's potential benefits in sobering up from alcohol intoxication FSD Pharma Inc. Biopharmaceutical Clinical Trial Unbuzzd™ Alcohol Metabolism
BRIEF published on 02/26/2024 at 14:00, 2 years 7 months ago FSD Pharma launches a clinical trial to test the effectiveness of unbuzzd™ FSD Pharma Clinical Test Unbuzzd™ Alcohol Metabolism Accelerated Sobriety
BRIEF published on 02/26/2024 at 14:00, 2 years 7 months ago FSD Pharma lance un essai clinique pour tester l'efficacité d'unbuzzd™ FSD Pharma Essai Clinique Unbuzzd™ Métabolisme De L'alcool Sobriété Accélérée
PRESS RELEASE published on 02/17/2024 at 01:10, 2 years 8 months ago FSD Pharma Announces US ATM Offering FSD Pharma announces an at-the-market offering agreement with H.C. Wainwright & Co., LLC to sell Class B Shares for up to US$11,154,232. The Company may use proceeds for clinical trials & general corporate purposes FSD Pharma Biopharmaceutical At-the-market Offering H.C. Wainwright & Co. Class B Shares
PRESS RELEASE published on 02/06/2024 at 13:00, 2 years 8 months ago Court of Appeal Dismisses Motion for Leave to Appeal Brought by Dr. Raza Bokhari, FSD Pharma Awards Total Approximately $3 Million FSD Pharma Inc. announced that the Court of Appeal for Ontario affirmed the Judgment entered by the Superior Court of Justice. The company also filed a Petition to Confirm Arbitration Awards in the United States District Court for the Eastern District of Pennsylvania FSD Pharma Inc. Court Of Appeal Biopharmaceutical Arbitration Awards Neurodegenerative Disorders
PRESS RELEASE published on 01/29/2024 at 22:30, 2 years 8 months ago FSD Pharma Announces Dr. Sanjiv Chopra is elected to FSD Pharma Board of Directors and Corporate Updates FSD Pharma appoints Dr. Sanjiv Chopra to its board of directors, replaces Nitin Kaushal. Also, the company retains SBS Intl Group LLC, Draper Inc., Carriage House Capital, Corp., IR Agency, Beyond Media, Issuer Direct for various services. FSD focuses on biopharmaceutical assets FSD Pharma Dr. Sanjiv Chopra Biopharmaceutical SBS Intl Group LLC IR Agency
PRESS RELEASE published on 01/16/2024 at 13:30, 2 years 9 months ago Update Provided on GBB Drink Lab, Inc. Litigation and Safety Shot FSD Pharma Inc., a biopharmaceutical company, provides an update on its litigation with GBB Drink Lab, Inc., denying allegations and moving for discovery. The company remains confident in its legal position and looks forward to vindicating its rights and exposing GBB and its bully tactics. Biopharmaceutical Company FSD Pharma Inc. Litigation Update GBB Drink Lab Inc. Alcohol Detoxification
PRESS RELEASE published on 12/23/2023 at 01:45, 2 years 9 months ago FSD Pharma Files Final Base Shelf Prospectus to Replace Expired Base Shelf Prospectus and Form F-3 Registration Statement with the SEC
PRESS RELEASE published on 12/05/2023 at 15:00, 2 years 10 months ago FSD Pharma Inc. Announces Closing of Private Placement FSD Pharma Inc. announces the closing of private placement and issuance of class A multiple voting shares at $1.90 per share for gross proceeds of $45.60. The proceeds will be used for general working capital purposes Private Placement FSD Pharma Inc. Financial News Investment Class A Multiple Voting Shares
PRESS RELEASE published on 11/30/2023 at 14:30, 2 years 10 months ago FSD Pharma Inc. and Celly Nutrition Corp. Announce Completion of Plan of Arrangement FSD Pharma Inc. and Celly Nutrition Corp. announce completion of Plan of Arrangement including distribution of Celly Nu Shares and New FSD Pharma Securities to FSD Pharma securityholders FSD Pharma Inc. Plan Of Arrangement Celly Nutrition Corp. Celly Nu Shares New FSD Pharma Securities
Published on 10/19/2026 at 09:05, 3 hours 20 minutes ago BioNxt Completes GMP Manufacturing and Submits Clinical Trial Application for Sublingual Cladribine Drug Candidate
Published on 10/17/2026 at 03:20, 2 days 9 hours ago Battery X Metals Highlights Participation at X Takeover 2026, an Electric Vehicle and Emerging Technology Event Held at Tesla's Gigafactory Texas, Providing Exposure to Industry Perspectives and Technology Developments
Published on 10/17/2026 at 03:15, 2 days 9 hours ago Vanta Closes Second Tranche of Private Placement Financing and Welcomes Launch of First U.S.-Listed Peptide ETF, Highlighting Growing Recognition of Peptide Industry
Published on 10/16/2026 at 23:35, 2 days 12 hours ago Initial Closing of US$3.4 Million Private Placement
Published on 10/16/2026 at 23:30, 2 days 12 hours ago NiobiumX Mining Inc. Announces Retraction of Recent Marketing Materials
Published on 10/19/2026 at 12:14, 11 minutes ago More Than a Trophy: Africa’s Moment to Champion Women’s Football (By Isha Johansen)
Published on 10/19/2026 at 11:55, 29 minutes ago HNS 2026 | Huawei Launches Newly Upgraded Stellar Intelligent Fabric for the European Market
Published on 10/19/2026 at 11:30, 54 minutes ago HNS 2026 | Huawei and Industry Organizations Release High-Quality 10 Gbps Intelligent Campus Network Technical and Standard White Paper in Europe
Published on 10/19/2026 at 11:45, 39 minutes ago Guillemot Corporation S.A. | Déclaration hebdomadaire des transactions sur actions propres du 12 au 16 octobre 2026
Published on 10/19/2026 at 11:45, 39 minutes ago Guillemot Corporation S.A. | Weekly report share buyback from October 12 to October 16, 2026
Published on 10/19/2026 at 10:49, 1 hour 35 minutes ago 261019 BENETEAU Transactions sur actions propres
Published on 10/19/2026 at 08:15, 4 hours 10 minutes ago Carrefour strengthens its leadership in convenience retail in France with the acquisition of Codifrance
Published on 10/19/2026 at 08:15, 4 hours 10 minutes ago Carrefour renforce son leadership dans le commerce de proximité en France avec l’acquisition de Codifrance